however, it is FDA-approved for the treatment of type 2 diabetes , not for weight loss
Pipeline Synergies: Lilly's ongoing development of retatrutide (triple agonist) suggests a strategy to maintain dominance in the incretin space, potentially leading to even more effective future treatments
This complex interplay of pro-angiogenic, cytoprotective, and anti-inflammatory signaling pathways makes BPC-157 a subject of intense investigation for understanding endogenous repair mechanisms
Dosing and Side Effects Semaglutide and tirzepatide often come with some gastrointestinal side effects, such as nausea, vomiting, diarrhea, constipation, and abdominal pain
2023 Sep 28;11:1254231
Beyond basic protection, GPx plays a role in fine-tuning cellular signals